- Home
- OLMA vs GIII Comparison
OLMA vs GIII Comparison
Compare OLMA & GIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLMA | GIII |
|---|---|---|
| Founded | 2006 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2020 | 2006 |
Fundamental Metrics
Financial Performance| Metric | OLMA | GIII |
|---|---|---|
| Price | $13.04 | $32.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | ★ $44.89 | $29.00 |
| AVG Volume (30 Days) | ★ 940.6K | 363.3K |
| Earning Date | 05-08-2026 | 06-05-2026 |
| Dividend Yield | N/A | ★ 1.29% |
| EPS Growth | ★ 15.00 | N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | N/A | ★ $2,957,012,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $21.66 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.89 | $20.33 |
| 52 Week High | $36.26 | $34.83 |
Technical Indicators
Market Signals| Indicator | OLMA | GIII |
|---|---|---|
| Relative Strength Index (RSI) | 37.44 | 60.33 |
| Support Level | $12.87 | $28.17 |
| Resistance Level | $17.23 | $34.83 |
| Average True Range (ATR) | 0.87 | 1.12 |
| MACD | -0.02 | 0.27 |
| Stochastic Oscillator | 18.78 | 83.27 |
Price Performance
Historical ComparisonAbout OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About GIII G-III Apparel Group LTD.
G-III Apparel Group Ltd is an apparel manufacturing company. The company makes a wide range of apparel, footwear, and accessories that sells under its own brands, licensed brands, and private-label brands. It has a substantial portfolio for licensed and proprietary brands, anchored by brands: DKNY, Donna Karan, Karl Lagerfeld, Karl Lagerfeld Paris, Vilebrequin, and others. The reportable segments of the company are Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, and sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenue from Wholesale operations.